Literature DB >> 28655511

Tobacco use as a screener for Clostridium difficile infection outcomes.

A K Barker1, A Van Galen2, A K Sethi1, D Shirley2, N Safdar3.   

Abstract

A retrospective cohort study was conducted to evaluate the utility of self-reported tobacco use for developing a clinical prediction rule for poor outcomes of Clostridium difficile infection. Patients with any history of smoking were significantly less likely than never smokers to be cured of their infection within two weeks. Disease recurrence, readmission within 30 days, death before treatment completion, and the severity of Clostridium difficile infection were not associated with smoking status. Published by Elsevier Ltd.

Entities:  

Keywords:  Clostridium difficile infection; Recurrence; Screening; Smoking status; Tobacco

Mesh：

Year:  2017        PMID： 28655511      PMCID： PMC5743584          DOI： 10.1016/j.jhin.2017.06.026

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN： 0195-6701            Impact factor:   3.926


  9 in total

1.  Clinical prediction rules.

Authors:  Simon T Adams; Stephen H Leveson
Journal:  BMJ       Date:  2012-01-16

2.  Analysis of the effects of cigarette smoke on staphylococcal virulence phenotypes.

Authors:  Elisa K McEachern; John H Hwang; Katherine M Sladewski; Shari Nicatia; Carola Dewitz; Denzil P Mathew; Victor Nizet; Laura E Crotty Alexander
Journal:  Infect Immun       Date:  2015-03-30       Impact factor: 3.441

3.  Cigarette smoking and the oral microbiome in a large study of American adults.

Authors:  Jing Wu; Brandilyn A Peters; Christine Dominianni; Yilong Zhang; Zhiheng Pei; Liying Yang; Yingfei Ma; Mark P Purdue; Eric J Jacobs; Susan M Gapstur; Huilin Li; Alexander V Alekseyenko; Richard B Hayes; Jiyoung Ahn
Journal:  ISME J       Date:  2016-03-25       Impact factor: 10.302

4.  Side-stream smoking reduces intestinal inflammation and increases expression of tight junction proteins.

Authors:  Hui Wang; Jun-Xing Zhao; Nan Hu; Jun Ren; Min Du; Mei-Jun Zhu
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

Review 5.  Cigarette smoking and infection.

Authors:  Lidia Arcavi; Neal L Benowitz
Journal:  Arch Intern Med       Date:  2004-11-08

6.  Accuracy of ICD-9 coding for Clostridium difficile infections: a retrospective cohort.

Authors:  D B Scheurer; L S Hicks; E F Cook; J L Schnipper
Journal:  Epidemiol Infect       Date:  2006-12-07       Impact factor: 2.451

Review 7.  Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison.

Authors:  Oliver A Cornely; Dilip Nathwani; Cristina Ivanescu; Olatunji Odufowora-Sita; Peny Retsa; Isaac A O Odeyemi
Journal:  J Antimicrob Chemother       Date:  2014-07-28       Impact factor: 5.790

8.  Higher rates of Clostridium difficile infection among smokers.

Authors:  Mary A M Rogers; M Todd Greene; Sanjay Saint; Carol E Chenoweth; Preeti N Malani; Itishree Trivedi; David M Aronoff
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

Review 9.  Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review.

Authors:  Claire Nour Abou Chakra; Jacques Pepin; Stephanie Sirard; Louis Valiquette
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240
  9 in total
  1 in total

1.  Long-term Outcomes Following Multiply Recurrent Clostridioides difficile Infection and Fecal Microbiota Transplantation.

Authors:  Ghadeer K Dawwas; Colleen M Brensinger; Ravy K Vajravelu; Qufei Wu; Colleen R Kelly; Loren Laine; Gary D Wu; James D Lewis
Journal:  Clin Gastroenterol Hepatol       Date:  2020-12-08       Impact factor: 11.382
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.